Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $110.51 | $24.61 | 349.03% | 208.51x | 189.42x | 14.02x | 16.93x | 1.61x | $106.92M | 0.92% | $705.78M | 6.70 | $11.84B | 1,509.79 | ||
| LQDA | LIQUIDIA CORP | $72.10 | $17.11 | 321.40% | 300.42x | 21.70x | 22.03x | 59.05x | 1.45x | $41.15M | 0.65% | $108.58M | 1.23 | $6.37B | 118.92 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $227.12 | $94.88 | 139.37% | 37.23x | 31.35x | 6.32x | 22.44x | 1.13x | $793.95M | 2.62% | $1.35B | 10.14 | $31.67B | 26.85 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.83 | $8.33 | 210.12% | 123.00x | 160.53x | 7.27x | 14.72x | 1.14x | $39.15M | 1.16% | $220.58M | 1.69 | $3.33B | 73.28 | ||
| RPRX | ROYALTY PHARMA PLC | $58.56 | $38.62 | 51.62% | 31.15x | 10.91x | 10.28x | 3.44x | 0.64x | $2.92B | 11.22% | $9.79B | 21.99 | $41.82B | 35.56 | ||
| VCEL | VERICEL CORP | $44.54 | $8.92 | 399.57% | 92.79x | 92.39x | 7.43x | 6.16x | 2.20x | $61.66M | 2.71% | $370.04M | 7.25 | $2.25B | 51.03 | ||
| HALO | HALOZYME THERAPEUTICS INC | $100.67 | $71.08 | 41.62% | 28.28x | 12.13x | 7.10x | 79.60x | 0.61x | $806.22M | 6.83% | $143.54M | 1.22 | $13.41B | 18.66 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.83 | $16.47 | 372.52% | 72.74x | 61.82x | 7.18x | 9.28x | 2.25x | $182.84M | 3.03% | $654.15M | 8.43 | $5.91B | 49.23 | ||
| ASND | ASCENDIS PHARMA A | $246.23 | $76.46 | 222.02% | 26.10x | 16.93x | 15.01x | 26.64x | 2.72x | $52.94M | 0.35% | $574.09M | 9.24 | $15.67B | 168.08 | ||
| KRYS | KRYSTAL BIOTECH INC | $328.34 | $86.61 | 279.11% | 39.70x | 43.05x | 22.01x | 7.15x | 2.34x | $257.78M | 2.66% | $1.36B | 46.03 | $9.30B | 39.86 | ||
| ADMA | ADMA BIOLOGICS INC | $9.41 | $8.76 | 7.42% | 13.07x | 11.22x | 4.19x | 5.16x | 0.59x | $116.47M | 5.42% | $408.21M | 1.79 | $2.17B | 9.31 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.05 | $2.24 | 35.93% | 15.25x | 13.19x | 1.87x | 2.92x | 0.79x | $5.67M | 2.36% | $82.53M | 1.04 | $176.92M | 9.47 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $68.53 | $21.30 | 221.81% | 180.34x | 18.45x | 3.89x | 2.10x | 1.13x | $738.18M | 5.57% | $6.32B | 32.68 | $16.58B | 42.98 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.18 | $9.47 | 18.06% | 11.77x | 10.80x | 4.86x | 3.05x | 0.76x | $82.01M | 12.40% | $217.65M | 3.68 | $520.09M | 6.73 | ||
| TGTX | TG THERAPEUTICS INC | $47.94 | $23.92 | 100.41% | 15.56x | 34.02x | 8.50x | 12.15x | 1.82x | $17.39M | 0.26% | $604.08M | 4.26 | $7.61B | 54.64 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $288.82 | $93.66 | 208.37% | 28.68x | 31.26x | 19.94x | 5.95x | 2.15x | $130.62M | 2.25% | $967.52M | 48.22 | $5.88B | 21.09 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $245.85 | $195.36 | 25.84% | 16.11x | 9.52x | 3.38x | 3.32x | 0.66x | $1.62B | 10.42% | $4.80B | 75.98 | $18.73B | 11.59 | ||
| TECH | BIO-TECHNE CORP | $72.17 | $15.99 | 351.48% | 101.65x | 34.59x | 9.32x | 5.42x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.38B | 44.46 | ||
| MDXG | MIMEDX GROUP INC | $4.20 | $1.11 | 278.41% | 105.00x | -37.43x | 1.75x | 2.83x | 1.48x | $44.50M | 7.17% | $216.00M | 1.46 | $493.56M | 21.64 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.24 | $6.46 | -80.80% | 8.86x | -4.19x | 1.53x | 1.63x | 0.07x | $19.58M | 27.26% | $44.20M | 0.76 | $23.48M | 3.07 | ||
| UTHR | UNITED THERAPEUTICS CORP | $501.27 | $224.02 | 123.76% | 16.58x | 18.32x | 6.77x | 19.19x | 2.23x | $1.09B | 5.12% | $6.40B | 150.24 | $121.01B | 72.18 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $805.97 | $415.76 | 93.86% | 19.22x | 17.26x | 5.33x | 2.62x | 1.26x | $3.76B | 4.54% | $31.71B | 308.48 | $83.23B | 14.47 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $516.44 | $157.43 | 228.04% | 29.80x | 26.71x | 10.41x | 6.46x | 2.36x | $3.80B | 2.90% | $20.25B | 79.81 | $126.73B | 23.03 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.50 | $32.86 | 17.15% | 12.26x | 10.14x | 2.32x | 2.24x | 0.72x | $354.90M | 15.91% | $999.24M | 17.25 | $1.85B | 6.59 | ||
| EXEL | EXELIXIS INC | $50.61 | $28.49 | 77.67% | 15.38x | 15.73x | 5.21x | 6.80x | 1.36x | $1.17B | 9.24% | $1.84B | 7.35 | $12.42B | 11.42 | ||
| INCY | INCYTE CORP | $120.52 | $60.30 | 99.87% | 14.84x | 15.86x | 4.15x | 3.85x | 1.99x | $1.92B | 7.95% | $6.34B | 31.66 | $20.48B | 9.90 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.